Literature DB >> 31669147

Genetic and Genomic Advances in Breast Cancer Diagnosis and Treatment.

Tammy L Walker-Smith, Jessica Peck.   

Abstract

Advances in genetic testing for people at high risk for cancer and in targeted gene therapy for breast cancer are rapidly emerging, including newly developed key hormone receptor-targeted therapies and individualized molecular fusion identification and treatment options. These advances are contributing to a new era in cancer treatment modalities and care delivery. As more innovative and advanced treatment options emerge, women's health outcomes and survival rates may improve. Nursing professionals in primary care and women's health specialties must be aware of the latest options for testing, referrals, and treatment modalities.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  BRCA1; BRCA2; breast cancer; genetic testing; genomic; primary care; target gene therapy; women’s health

Mesh:

Year:  2019        PMID: 31669147     DOI: 10.1016/j.nwh.2019.09.003

Source DB:  PubMed          Journal:  Nurs Womens Health        ISSN: 1751-4851


  3 in total

1.  Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer.

Authors:  Lin Li; Xi Zhang; Yuqi Li; Bo Xiao; Sibiao Pei; Hangyu Jiang; Xiaofen Zhang
Journal:  Int J Mol Med       Date:  2022-07-07       Impact factor: 5.314

2.  Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast.

Authors:  Maahum Mehdi; Amanda L Kong; Julia Frebault; Shane Huang; Chiang-Ching Huang; Chandler S Cortina
Journal:  J Surg Res       Date:  2021-04-03       Impact factor: 2.417

3.  Ultrasound microbubble-mediated RNA interference targeting WNT1 inducible signaling pathway protein 1(WISP1) suppresses the proliferation and metastasis of breast cancer cells.

Authors:  Faying Fang; Weizhi Xu; Jian Zhang; Jin Gu; Gaoyi Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.